Twist Bioscience
(NASDAQ) TWST
Twist Bioscience Financials at a Glance
Market Cap
$3.48B
Revenue (TTM)
$391.56M
Net Income (TTM)
$76.58M
EPS (TTM)
$-1.27
P/E Ratio
-44.49
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Price
$58.64
Volume
1,552,584.753
Open
$57.50
Price
$58.64
Volume
1,552,584.753
Open
$57.50
Previous Close
$58.45
Daily Range
$56.74 - $60.60
52-Week Range
$23.30 - $66.06
Dividend
$0.00
Beta (Volatility)
2.35 (High)
Price
$58.64
Volume
1,552,584.753
Open
$57.50
Previous Close
$58.45
Daily Range
$56.74 - $60.60
52-Week Range
$23.30 - $66.06
TWST News
Best Biotech ETFs to Buy in 2026
TWST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Twist Bioscience
Industry
Biotechnology
Sector
Health CareEmployees
979
CEO
Emily Marine Leproust, PhD
Website
www.twistbioscience.comHeadquarters
South San Francisco, CA 94080, US
TWST Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
-34%
Net Income Margin
-20%
Return on Equity
-17%
Return on Capital
-24%
Return on Assets
-12%
Earnings Yield
-2.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.48B
Shares Outstanding
61.31M
Volume
1.55M
Avg. Volume
1.31M
Financials (TTM)
Gross Profit
$191.00M
Operating Income
$136.26M
EBITDA
$52.10M
Operating Cash Flow
$47.63M
Capital Expenditure
$28.00M
Free Cash Flow
$75.63M
Cash & ST Invst.
$232.43M
Total Debt
$137.32M
Twist Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$103.70M
+16.9%
Gross Profit
$53.97M
+26.0%
Gross Margin
52.05%
N/A
Market Cap
$3.48B
N/A
Market Cap/Employee
$3.77M
N/A
Employees
923
N/A
Net Income
$30.51M
+3.4%
EBITDA
$24.06M
+4.1%
Quarterly Fundamentals
Net Cash
$14.09M
-92.5%
Accounts Receivable
$50.06M
+27.3%
Inventory
$32.92M
+40.0%
Long Term Debt
$171.62M
+153.9%
Short Term Debt
$12.24M
-18.5%
Return on Assets
-12.00%
N/A
Return on Invested Capital
-24.12%
N/A
Free Cash Flow
$34.79M
-46.8%
Operating Cash Flow
$24.81M
-15.8%